- Postgraduate taught degree courses
- Postgraduate taught tuition fees
- Pre-masters for international students
- Funding your postgraduate taught studies
- How to apply for a postgraduate taught degree
- Postgraduate offer holders - prepare for your studies
- Choose your halls of residence
- Apply for accommodation
- Guaranteed accommodation
- Your accommodation options
- Accommodation for those with additional requirements
- International and pre-sessional students
- Postgraduate accommodation
- Renting privately
- Our accommodation areas
- Privacy notice
- Terms and conditions
- Fees and contracts
Research project
Susceptibility of Patient derived xenograph (PDX) models of Leukemia/lymphoma to cerdulatinib alone or in combination with venetoclax or rituximab
-
Other researchers:
-
Research funder:Portola Pharmaceuticals
-
Status:Not active